Effect of "Nicotinamide Mononucleotide" (NMN) on Cardiometabolic Function

Completed · Not applicable · Has a placebo group

Conditions studied: Glucose Metabolism Disorders

In brief

The purpose of the study is to understand the effect of the dietary supplement "Nicotinamide mononucleotide" on metabolic health in people.

Key facts

Study ID
NCT03151239
Run by
Washington University School of Medicine
People needed
25
Starts
2017-07-01
Expected to finish
2021-06-30
Last updated by the study team
2021-07-14

Who can join

Age: 55 and older, up to 75. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.